Project Grant K08DA062758
- Federal Grant Award Summary The Ohio State University received a $367,806 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025 and concluding July 31, 2030. The grant supports a mixed-methods hybrid Type 2 effectiveness-implementation feasibility trial evaluating the TBI-RECOVER intervention model for substance use disorder (SUD) treatment settings. The research addresses a critical gap in clinical...
- Federal Grant Award Summary Ohio University received a $982,736 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective March 15, 2026, with completion targeted for December 31, 2029. The award funds the Buprenorphine Prescribing Support Program (BPSP) for Rural Primary Care, a community-engaged implementation effectiveness research initiative designed to expand access to buprenorphine treatment in rural...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Trustees of Boston University a $193,751 Project Grant effective May 1, 2026, through April 30, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This Career Development Award supports a rigorous training and research plan to develop an independent substance use disorder (SUD) services researcher whose work will advance large-scale improvements in SUD care quality. The award funds...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $389,271 Project Grant to the University of Pennsylvania on April 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This five-year award, extending through March 31, 2030, supports research on methadone loading dose initiation protocols for hospitalized patients with opioid use disorder (OUD) who use fentanyl. Dr. Ashish Thakrar, an addiction medicine specialist and...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke awarded The Ohio State University a $10.1 million Project Grant on September 12, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the MODEL-PAIN study. This four-year research initiative (through August 31, 2029) will characterize the diverse experiences and longitudinal trajectories of acute pain in emergency department (ED) settings, where over 80% of approximately...
- Federal Grant Award Summary The University of Central Florida Board of Trustees received a $1.59 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to evaluate state policies facilitating emergency department-based treatment initiation for opioid use disorder (OUD). The award, effective August 1, 2025, through May 31, 2030, addresses the critical gap in medications for opioid use disorder (MOUD) prescribing in...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $3.1 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School, with an award date of September 1, 2025, and a completion date of May 31, 2030. This research initiative, titled "Improving Jail Response to the Overdose Crisis," delivers a hybrid trial implementation strategy to increase access to Medication for Opioid Use...
- Federal Grant Award Summary Dartmouth College received a $147,486 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 12, 2025, with a completion date of November 30, 2027. The research project, titled "Identifying Modifiable Momentary Predictors of Substance Use in High Risk Emergency Medical Services Clinicians," delivers longitudinal research services examining substance use patterns among...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Henry Ford Health + Michigan State University Health Sciences a Project Grant totaling $529,990 under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 15, 2025, with completion targeted for May 31, 2028. The award funds development and testing of an adaptive psychological intervention designed to reduce prolonged opioid use and improve pain management among patients...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $2.3 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 1, 2025, with completion targeted for March 31, 2030. The award funds a research study examining the impact of telehealth expansion on opioid use disorder (OUD) treatment delivery within community health centers (CHCs). Using approximately a decade of...
The National Institute on Drug Abuse (NIDA) awarded a $189,000 Project Grant to The Ohio State University on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). This Career Development Award supports the development of an independent clinician-scientist capable of designing and evaluating Emergency Medical Services (EMS)-based interventions for substance use disorders (SUD), with a specific focus on the opioid epidemic. The research plan delivers didactic coursework, experiential training, and mentorship to the candidate, along with rigorous evaluation of an exemplar Post-Overdose Quick Response Team (QRT) in Columbus, Ohio. The grant funds prospective evaluation and research services to assess EMS-based community outreach strategies for individuals at-risk for overdose. The research deliverables include evaluation of Mobile Integrated Healthcare & Community Paramedicine (MIH-CP) approaches that expand traditional EMS functions to include community outreach, harm reduction, treatment linkage, and recovery support services. The project addresses a critical gap in evidence-based practices by evaluating both reactive post-overdose interventions and innovative proactive pre-overdose outreach strategies that address polysubstance use disorders. The five-year project period extends through February 28, 2031, and is conducted at The Ohio State University's Office of Sponsored Programs in Columbus, Ohio.Summary of Federal Project Grant Award
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $189.0k | 3/4/26 |